News & Events

3D rendering of genetic medicine with DNA isolated on white background.

Find out about the latest news and events from NCATS and from its partners.

NCATS Co-leads Bespoke Gene Therapy Consortium to Address Rare Diseases

NIH, FDA and 15 private organizations launched the Bespoke Gene Therapy Consortium to increase the number of effective gene therapies for rare diseases. NCATS co-leads the effort, which is part of NIH’s Accelerating Medicines Partnership® program.

Illustration of a cytokine storm response to infection with the new coronavirus SARS-CoV-2.

NCATS-Supported Clinical Trial Shows Survival Improvement for People Hospitalized with COVID-19

NCATS coordinated and oversaw the ACTIV-1 Immune Modulators clinical trial, which found that two immune modulator drugs substantially improved clinical status and reduced deaths for adults hospitalized with COVID-19.

A graphic image that has stylized depictions of facts and statistics from the publication, The IDeaS Initiative: Pilot Study to Assess the Impact of Rare Diseases on Patients and Healthcare Systems. Title: Rare diseases, individually rare, collectively common. Text: The medical costs of rare diseases have been underestimated; rare diseases are collectively common, affecting an estimated 25–30 million people in the United States; individual medical costs for people with a rare disease are 3–5 times greater t

Pilot Study Finds Nationwide Medical Costs for Rare and Some Common Diseases are Likely Similar

An NCATS-led study finds that the number of individuals with rare diseases and their medical costs have been underestimated, suggesting that nationwide health care costs associated with rare diseases are likely similar to common diseases such as cancer.

Releases & Announcements

Read the latest news from NCATS and other NIH Institutes and Centers that collaborate with NCATS scientists.

Media Coverage

Follow media coverage of NCATS' and its partners' translational research activities through national and local media outlets.

Grantee & Partner News

Check out news from NCATS grantees and partners whose research is supported through the Center’s programs, in-kind services and collaborations.

Events

Get details about upcoming NCATS-supported events and view materials from past events.

Media Contact

NCATS media inquiries are handled by the Center's communications team. For more information or to request an interview:

Email the NCATS Communications Branch.
Call the NCATS Information Officer at 301-435-0888.

Feature Stories

NCATS-supported scientists are engaged in cutting-edge translational research activities across the United States. Discover the behind-the-scenes work and Center support that made the latest advances possible.

Subscribe for Updates